Although dysfunctions of AR/TGF-β signaling had been reported to play critical roles in prostate cancer progression, the transcript levels of individual PMEPA1 isoforms (d and e) were not found to associate with disease aggressiveness such as Gleason score in TCGA dataset of human prostate cancer patients. The gene discussed is PMEPA1; the disease is prostate carcinoma.